tykhr
sign in
free sign up
Trillium Therapeutics Inc
Biotechnology
Healthcare
TRIL
104M shares
NASDAQ US
traded
16 Nov 2021
open
17.92
52 week high
20.13
high
18.49
52 week low
5.86
low
17.83
growth
-6.25%
previous Close
17.97
P/E ratio
-102
market cap
1.85B
div yield
0
usd
Jun 2021
qoq
revenue
10.00K
-69.70 %
net incoming
-18.40M
-69.39 %
eps
-0.18
-63.58 %
eps surprise
-26.83 %
net profit margin
-183990 %
-151074.00 %
operating incoming
-18.67M
-64.98 %
net change in cash
-78.07M
-25,695.41 %
cash on hand
170M
-31.49 %
cost of revenue
top